Department of Science, Tchaikapharma High Quality Medicines, Bulgaria
Research Article
Repurposing of Favipiravir for the Treatment COVID-19: A Meta-analysis
Author(s): Velichka Pavlova, Katya Uzunova, Elena Filipova, Krassimir Kalinov and Toni Vekov
Background: The outbreak of coronavirus disease 2019 (COVID-19) originating from Wuhan, Hubei Province, China at the end of 2019 led to dramatic changes in the healthcare and socioeconomic sectors across the globe. The aim of this meta-analysis was to assess whether favipiravir is a safe and effective option for treatment of COVID-19 patients compared with standard of care (SOC) and/or other applied medicines.
Methods: Data bases were searched up to 31st May 2021 for studies that compare the efficacy and safety of favipiravir and SOC or other relevant therapy in COVID-19 patients. Search results were assessed for relevance on the basis of the following inclusion criteria and relevant results were subjected to a quality estimation using the EPHPP Quality assessment tool.
Results: A total of 10 articles wi.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 